A cough lasting more than three weeks could signal underlying health issues. Know possible causes, red flags, and when medical attention becomes essential.

A cough, while common, can signal various underlying conditions ranging from minor irritations to serious health concerns. Dr. Fady Youssef, a board-certified pulmonologist, explains that ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Chronic cough took center stage at the European Respiratory Society (ERS) Congress session titled "Conditions We Are Just Dealing With the Tip of the Iceberg in Primary Care: Frequently Mismanaged ...

Add Yahoo as a preferred source to see more of our stories on Google. Coughs are common during every winter virus season. But this year it seems like more people than usual are complaining about a ...

If you've found yourself dealing with a nasty, lingering cough, you're not alone. With respiratory illnesses surging across the country right now, it's no surprise that so many people are hacking for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with chronic vs. non-chronic cough faced a higher ...

Based on the researchers’ findings, gefapixant provides small benefits in cough severity, cough frequency, and cough-specific quality of life in patients with refractory or unexplained chronic coughs.

If standard therapies don’t give relief to patients with refractory cough associated with interstitial lung disease, maybe a little poison could do the trick. Among 41 patients with idiopathic ...

Coughs from different illnesses have specific sounds that can help make a diagnosis. Learn about the sounds of a bronchitis cough. Share on Pinterest arto_canon/Getty Images When a healthcare ...

An FDA advisory committee has voted against approving Merck & Co.’s gefapixant, a P2X3 receptor antagonist medicine designed to treat adults with chronic cough—a decision the Big Pharma disagrees with ...